U.S. FDA clears Abbott’s blood test to evaluate concussion
March 7 (Reuters) – The U.S. Food and Drug Administration has cleared Abbott Laboratories’ (ABT.N) blood test that would help doctors assess traumatic brain injury (TBI), commonly known as concussions, … Read More